دورية أكاديمية
Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
العنوان: | Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study. |
---|---|
المؤلفون: | Friedman MA, Kaufman DA, Williams JE, Resser KJ, Rosenbaum EH, Cohen RJ, Glassberg AB, Blume MR, Gershow J, Chan EY |
المصدر: | Cancer treatment reports [Cancer Treat Rep] 1979 Mar; Vol. 63 (3), pp. 493-5. |
نوع المنشور: | Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. |
اللغة: | English |
بيانات الدورية: | Publisher: National Cancer Institute [etc.] Country of Publication: United States NLM ID: 7607107 Publication Model: Print Cited Medium: Print ISSN: 0361-5960 (Print) Linking ISSN: 03615960 NLM ISO Abbreviation: Cancer Treat Rep Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Silver Spring, Md., : Washington, National Cancer Institute [etc.] ; for sale by the Supt. of Docs., U. S. Govt. Print. Off. |
مواضيع طبية MeSH: | Cisplatin/*therapeutic use , Dacarbazine/*therapeutic use , Melanoma/*drug therapy , Triazenes/*therapeutic use, Adolescent ; Adult ; Aged ; Child ; Cisplatin/adverse effects ; Clinical Trials as Topic ; Dacarbazine/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis |
المشرفين على المادة: | 0 (Triazenes) 7GR28W0FJI (Dacarbazine) Q20Q21Q62J (Cisplatin) |
تواريخ الأحداث: | Date Created: 19790301 Date Completed: 19790629 Latest Revision: 20131121 |
رمز التحديث: | 20231215 |
PMID: | 371802 |
قاعدة البيانات: | MEDLINE |
تدمد: | 0361-5960 |
---|